To determine the prevalence of PTEN mutations, we performed mutation analysis of PTEN exons 5−9 and flanking intronic sequences in 154 patients with newly diagnosed CLL. The gene discussed is PTEN; the disease is B-cell chronic lymphocytic leukemia.